GSK717是一种强效且选择性的NOD2(核苷酸结合寡聚化结构域2)抑制剂,GSK717能够抑制小肽(MDP)诱导的NOD2介导的信号传导,在HEK293/hNOD2细胞中其IC50为400 nM,并减少MDP刺激的IL-8分泌。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | As a NLR family member, NOD2 (nucleotide-binding oligomerization domain 2) is an intracellular pattern recognition receptor that assembles with receptor-interacting protein (RIP)-2 kinase in response to the presence of bacterial muramyl dipeptide (MDP) in the host cell cytoplasm, thereby inducing signals leading to the production of pro-inflammatory cytokines. GSK717 is a potent and selective NOD2 inhibitor. GSK717 (0.5-16 μM; 1 hour) blocked synergy between NOD2 and TLR2 (Toll-like receptor 2) in primary human monocytes. GSK717 does not affect NOD1, TNFR1 (tumour necrosis factor receptor-1) and TLR2-mediated responses. GSK717 (5 μM) inhibited the release of IL-8, IL-6, TNFα and IL-1β in primary human monocytes stimulated with MDP (muramyl dipeptide). GSK717 inhibited MDP-induced NOD2-mediated signaling with an IC50 of 400 nM for IL-8 secretion stimulated by MDP in HEK293/hNOD2 cells[2]. |
| Concentration | Treated Time | Description | References | |
| neutrophils | 20 ug/mL | 8 hours | GSK717, as a NOD2 receptor inhibitor, was used to study the mechanism of Fn-induced neutrophil extracellular traps (NETs) formation. Results showed that GSK717 significantly suppressed Fn-induced NETs formation (detected by CitH3 and MPO-DNA levels). | J Exp Clin Cancer Res. 2023 Sep 9;42(1):236 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.21mL 0.44mL 0.22mL |
11.05mL 2.21mL 1.10mL |
22.10mL 4.42mL 2.21mL |
|
| CAS号 | 1595278-21-9 |
| 分子式 | C28H28N4O2 |
| 分子量 | 452.55 |
| SMILES Code | O=C(C=1C=CC=CC1)N(C)CCC2=NC=3C=CC=CC3N2CC(=O)NC4=CC=C5C(=C4)CCC5 |
| MDL No. | MFCD32671947 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | YDOATJUIIFWTKQ-UHFFFAOYSA-N |
| Pubchem ID | 102369397 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 250 mg/mL(552.43 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1